A Closer Look at the Lecanemab Clinical Trials
In a special episode of Dementia Matters, Drs. Cynthia Carlsson and Sterling Johnson join the podcast to discuss what they know from lecanemab’s clinical trials following the U.S. Food and Drug Admini...
16 Helmi 202336min
Therapeutic Fibbing: Mastering the Art of Communicating with a Loved One with Dementia
Former Governor of Wisconsin, Martin Schreiber, returns to Dementia Matters to discuss different methods for communicating with a loved one with Alzheimer’s disease, including therapeutic fibbing. Gov...
7 Helmi 202326min
The Future of the Alzheimer’s Association: Interview with Dr. Joanne Pike and Harry Johns
In October 2022, the Alzheimer's Association named Dr. Joanne Pike, the current president of the Association, as the next CEO, succeeding Harry Johns who has served as CEO since 2005. In this episode,...
24 Tammi 202332min
Introducing Lecanemab, the Latest Alzheimer’s Disease Drug to Receive FDA Accelerated Approval
Host Nathaniel Chin, MD, gives an overview of the new Alzheimer’s treatment Leqembi (lecanemab), and highlights results from the second and third phases of its clinical trials. On January 6, 2023, the...
17 Tammi 202320min
Healthy Habits for the New Year and Modifiable Risk Factors for Alzheimer’s Disease
Host Nathaniel Chin, MD, starts the new year by discussing modifiable risk factors for Alzheimer’s disease, commenting on building healthy lifestyle habits for the new year, and reflecting as Dementia...
10 Tammi 202314min
Bioenergetics: How Mitochondria Affects Alzheimer’s Disease and Aging
It’s generally known that mitochondria are the powerhouse of cells, but did you know they can play a significant role in aging processes? Through the field of bioenergetics, scientists are looking to ...
29 Joulu 202225min
Looking Toward the Future: How Preclinical Alzheimer’s Disease Biomarker Disclosures Impact Society
The field of biomarkers is advancing quickly, allowing preclinical Alzheimer’s disease to be identified earlier and earlier in a person’s life. As individuals learn they are at risk for Alzheimer’s ye...
13 Joulu 202237min
Mixed Dementia, Explained
Though brain and cognitive changes are typically diagnosed as one form of dementia, recent studies have shown that mixed dementia is more common than previously thought. Mixed dementia, also known as ...
29 Marras 202228min
